Skip to content Skip to footer
Romosozumab-Aqqg: Benefits, Reviews, Info, Side Effects!
Rx Details
Romosozumab-Aqqg
Evenity
Romosozumab-Aqqg
Prescription
Drug
Drugs
Prescription Only
increases bone formation, decreases bone resorption, improves bone mineral density, reduces risk of fractures in postmenopausal women with osteoporosis
Cardiovascular Events, Headache, Hypersensitivity Reactions, Injection Site Reactions, Joint Pain, Low Calcium Levels, Muscle Spasms
Romosozumab-aqqg, marketed under the brand name Evenity, is a medication used for the treatment of osteoporosis in postmenopausal women at high risk for fracture. The typical dosage for Romosozumab-aqqg is 210 mg administered as two subcutaneous injections of 105 mg each, once a month. The treatment duration is usually 12 months. However, it’s important to follow the specific guidance of a healthcare provider, as they will tailor the treatment to the individual patient’s needs.
Osteoporosis
Romosozumab-Aqqg has a favorable safety profile.
No Interactions Reported
$1,000 – $1,500
$1,250

A Synopsis of

Romosozumab-Aqqg

Romosozumab-Aqqg is a medication that is used to treat osteoporosis in postmenopausal women who are at high risk for fractures. This drug works by increasing bone formation and decreasing bone resorption, ultimately leading to stronger bones and a reduced risk of fractures.

It is important to note that Romosozumab-Aqqg is typically administered as an injection under the skin once a month. It is important to follow the dosing schedule provided by your healthcare provider to ensure the best results.

As with any medication, there are potential side effects to be aware of when taking Romosozumab-Aqqg. Some common side effects may include joint pain, headache, and injection site reactions. It is important to discuss any concerns or side effects with your healthcare provider.

It is also important to inform your healthcare provider of any other medications or supplements you may be taking, as they could interact with Romosozumab-Aqqg. Your healthcare provider will be able to provide guidance on the best course of action for your individual situation.

Overall, Romosozumab-Aqqg is a valuable treatment option for postmenopausal women at high risk for fractures due to osteoporosis. By increasing bone formation and decreasing bone resorption, this medication can help improve bone health and reduce the risk of fractures. If you have any questions or concerns about Romosozumab-Aqqg, be sure to discuss them with your healthcare provider.

RxDb Legal Disclaimer

The information provided on RxDB.net is for informational purposes only and is not intended to replace professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare professional, such as a doctor or pharmacist, for any questions or concerns regarding your health, medications, or medical conditions. Reliance on any information provided on this website is solely at your own risk. RxDB.net does not provide medical or pharmaceutical services and is not liable for any decisions made based on the information contained herein.

PAGE LAST UPDATED

Health Education Through Aggregation

Sign up for the Rx Database Newsletter!
Menu
Questions?

Website By Foxco © 2025. All rights reserved.

0
Would love your thoughts, please comment.x
()
x
en_USEN